Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR

NCT00001698 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

NIH

Sponsor class

Conditions

Leukoplakia
Periodontal Disease

Interventions

DRUG: Ketorolac Rinse

Sponsor

National Cancer Institute (NCI)